Filter
1511
Filtered Results: 1511
Text search:
World
Confederation
for
Physical
Therapy
Featured
Recommendations
179
New Publications
398
Language
Document type
No document type
999
Guidelines
218
Studies & Reports
133
Manuals
93
Strategic & Response Plan
40
Training Material
12
Fact sheets
9
Resource Platforms
3
Situation Updates
2
Brochures
1
App
1
Countries / Regions
India
89
Global
56
Kenya
45
South Africa
33
Uganda
33
Ethiopia
31
Nepal
27
Nigeria
27
Western and Central Europe
26
Sierra Leone
24
Tanzania
22
Zambia
22
Liberia
21
Ghana
18
Rwanda
18
Malawi
18
Namibia
17
Myanmar / Burma
17
Philippines
16
Lesotho
15
Syria
13
Zimbabwe
13
Latin America and the Carribbean
13
Bangladesh
13
Cambodia
11
Eastern Europe
11
Africa
10
Botswana
10
Ukraine
9
Asia
7
South Sudan
7
Indonesia
7
Eswatini/ Swaziland
6
Haiti
5
Germany
5
Western Pacific Region
5
Cameroon
4
Afghanistan
4
USA
4
Guinea
3
Mozambique
3
West and Central Africa
3
Lebanon
3
Tajikistan
2
Thailand
2
Senegal
2
Kyrgyzstan
2
Peru
2
Congo, Democratic Republic of
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Southern Africa
2
Vietnam
2
Brazil
2
Moldova
2
Russia
2
Bhutan
2
Iraq
2
Somalia
2
Pakistan
2
North Macedonia
1
North Korea
1
Timor Leste/ East Timor
1
Australia
1
Benin
1
China
1
Kazakhstan
1
Singapore
1
Laos
1
Niger
1
Burkina Faso
1
Hungary
1
Jordan
1
Ireland
1
Paraguay
1
Jamaica
1
Sri Lanka
1
Egypt
1
Sudan
1
Yemen
1
Palestine
1
Georgia
1
Central African Republic
1
Poland
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
540
Clinical Guidelines
169
Public Health
107
Women & Child Health
96
Key Resources
71
Capacity Building
26
Pharmacy & Technologies
10
Toolboxes
Mental Health
178
HIV
136
Disability
82
TB
75
COVID-19
67
Caregiver
55
NCDs
47
Pharmacy
40
Conflict
37
Rapid Response
32
NTDs
28
Refugee
25
Ebola & Marburg
23
AMR
14
Planetary Health
12
Natural Hazards
11
Social Ethics
9
Global Health Education
9
Specific Hazards
8
Polio
8
Cholera
4
Zika
4
Health Financing Toolbox
3
Malaria
1
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
first issued 18 August 2022
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
A framework for action provides a guide for those involved in the development of the multisectoral action plan. It starts with a wide-ranging vision and, through a series of increasingly specific intentions, brings into focus actions with measurable outcomes that can be taken to achieve that vision.
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
A policy brief on the organization of prison health
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
2016 Update
Key population
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Guidelines
Key Populations
A handbook for leaders and managers
